西妥昔-话题@MedSci

#西妥昔#

72篇内容 | 2299人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1679418, encodeId=62c616e9418c8, content=<a href='/topic/show?id=d2ea9048398' target=_blank style='color:#2F92EE;'>#西妥昔#</a>, objectTitle=WCLA 2013:同步放化疗联合西妥昔单抗治疗, objectType=article, longId=26422, objectId=6be8264220c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6be8264220c, replyNumber=0, likeNumber=75, createdTime=2014-07-29, rootId=0, userName=chengjn, userId=271a27776763, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6be8264220c, moduleTitle=WCLA 2013:同步放化疗联合西妥昔单抗治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6be8264220c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1679421, encodeId=fdc916e942170, content=<a href='/topic/show?id=d2ea9048398' target=_blank style='color:#2F92EE;'>#西妥昔#</a>, objectTitle=NEJM：西妥昔单抗方案对纵隔B细胞淋巴瘤有较高治愈率, objectType=article, longId=32508, objectId=f0633250802, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0633250802, replyNumber=0, likeNumber=64, createdTime=2014-07-21, rootId=0, userName=chengjn, userId=271a27776763, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0633250802, moduleTitle=NEJM：西妥昔单抗方案对纵隔B细胞淋巴瘤有较高治愈率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0633250802)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1679412, encodeId=3d0316e9412c1, content=<a href='/topic/show?id=d2ea9048398' target=_blank style='color:#2F92EE;'>#西妥昔#</a>, objectTitle=Lancet Oncol：不推荐根治性放化疗合并西妥昔单抗治疗食管癌, objectType=article, longId=17963, objectId=ff9a1e9633f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff9a1e9633f, replyNumber=0, likeNumber=82, createdTime=2013-06-26, rootId=0, userName=chengjn, userId=271a27776763, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff9a1e9633f, moduleTitle=Lancet Oncol：不推荐根治性放化疗合并西妥昔单抗治疗食管癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff9a1e9633f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1679413, encodeId=571816e94137e, content=<a href='/topic/show?id=d2ea9048398' target=_blank style='color:#2F92EE;'>#西妥昔#</a>, objectTitle=Lancet Oncol：在卡培他滨-顺铂基础上联用西妥昔单抗不能改善晚期胃癌患者临床预后, objectType=article, longId=18831, objectId=158c1883170, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=158c1883170, replyNumber=0, likeNumber=80, createdTime=2013-12-22, rootId=0, userName=chengjn, userId=271a27776763, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=158c1883170, moduleTitle=Lancet Oncol：在卡培他滨-顺铂基础上联用西妥昔单抗不能改善晚期胃癌患者临床预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=158c1883170)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1679416, encodeId=67af16e9416ab, content=<a href='/topic/show?id=d2ea9048398' target=_blank style='color:#2F92EE;'>#西妥昔#</a>, objectTitle=JCO：肿瘤早期萎缩情况可预测含西妥昔单抗一线治疗的转移性结直肠癌患者长期结局, objectType=article, longId=25285, objectId=05eb25285aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=05eb25285aa, replyNumber=0, likeNumber=69, createdTime=2013-11-14, rootId=0, userName=chengjn, userId=271a27776763, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=05eb25285aa, moduleTitle=JCO：肿瘤早期萎缩情况可预测含西妥昔单抗一线治疗的转移性结直肠癌患者长期结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=05eb25285aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1679415, encodeId=f14c16e941552, content=<a href='/topic/show?id=d2ea9048398' target=_blank style='color:#2F92EE;'>#西妥昔#</a>, objectTitle=JCO：西妥昔单抗联合顺铂可改善三阴性乳腺癌患者生存, objectType=article, longId=20829, objectId=33962082990, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33962082990, replyNumber=0, likeNumber=68, createdTime=2013-12-13, rootId=0, userName=chengjn, userId=271a27776763, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33962082990, moduleTitle=JCO：西妥昔单抗联合顺铂可改善三阴性乳腺癌患者生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33962082990)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1679414, encodeId=682916e941424, content=<a href='/topic/show?id=d2ea9048398' target=_blank style='color:#2F92EE;'>#西妥昔#</a>, objectTitle=ASCO 2013：头对头研究显示晚期结肠癌一线治疗西妥昔单抗优于贝伐单抗, objectType=article, longId=19577, objectId=bf9e195e744, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf9e195e744, replyNumber=0, likeNumber=56, createdTime=2014-01-12, rootId=0, userName=chengjn, userId=271a27776763, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf9e195e744, moduleTitle=ASCO 2013：头对头研究显示晚期结肠癌一线治疗西妥昔单抗优于贝伐单抗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf9e195e744)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1679410, encodeId=416916e9410d9, content=<a href='/topic/show?id=d2ea9048398' target=_blank style='color:#2F92EE;'>#西妥昔#</a>, objectTitle=JAMA：FOLFOX方案添加西妥昔单抗治疗结肠癌并未获益, objectType=article, longId=7682, objectId=8926e682b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8926e682b9, replyNumber=0, likeNumber=83, createdTime=2013-01-25, rootId=0, userName=chengjn, userId=271a27776763, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8926e682b9, moduleTitle=JAMA：FOLFOX方案添加西妥昔单抗治疗结肠癌并未获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8926e682b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1679408, encodeId=6aaa16e940867, content=<a href='/topic/show?id=d2ea9048398' target=_blank style='color:#2F92EE;'>#西妥昔#</a>, objectTitle=JAMA：结肠癌术后西妥昔单抗不改善患者无病存活率, objectType=article, longId=5019, objectId=490750196b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=490750196b, replyNumber=0, likeNumber=73, createdTime=2012-11-19, rootId=0, userName=chengjn, userId=271a27776763, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=490750196b, moduleTitle=JAMA：结肠癌术后西妥昔单抗不改善患者无病存活率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=490750196b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1679407, encodeId=7fb116e940785, content=<a href='/topic/show?id=d2ea9048398' target=_blank style='color:#2F92EE;'>#西妥昔#</a>, objectTitle=JAMA：结肠癌术后添加西妥昔单抗的疗效, objectType=article, longId=4987, objectId=1029498ee9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1029498ee9, replyNumber=0, likeNumber=61, createdTime=2012-04-29, rootId=0, userName=chengjn, userId=271a27776763, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1029498ee9, moduleTitle=JAMA：结肠癌术后添加西妥昔单抗的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1029498ee9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1679411, encodeId=1de716e9411c1, content=<a href='/topic/show?id=d2ea9048398' target=_blank style='color:#2F92EE;'>#西妥昔#</a>, objectTitle=JCO：西妥昔单抗升级剂量治疗转移性结直肠癌, objectType=article, longId=8341, objectId=81ca834123, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81ca834123, replyNumber=0, likeNumber=69, createdTime=2012-09-11, rootId=0, userName=chengjn, userId=271a27776763, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81ca834123, moduleTitle=JCO：西妥昔单抗升级剂量治疗转移性结直肠癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=81ca834123)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1679409, encodeId=71ba16e940947, content=<a href='/topic/show?id=d2ea9048398' target=_blank style='color:#2F92EE;'>#西妥昔#</a>, objectTitle=Annal Onco：西妥昔单抗/吉西他滨/调强放疗（IMRT）新辅助化放疗治胰腺导管腺癌有效, objectType=article, longId=6201, objectId=15dd6201a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=15dd6201a1, replyNumber=0, likeNumber=69, createdTime=2012-11-23, rootId=0, userName=chengjn, userId=271a27776763, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=15dd6201a1, moduleTitle=Annal Onco：西妥昔单抗/吉西他滨/调强放疗（IMRT）新辅助化放疗治胰腺导管腺癌有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=15dd6201a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

西妥昔

2020-05-29

chengjn (审核中...)

前往app查看评论内容

#西妥昔#

WCLA 2013:同步放化疗联合西妥昔单抗治疗

2014-07-29

chengjn (审核中...)

前往app查看评论内容

#西妥昔#

NEJM：西妥昔单抗方案对纵隔B细胞淋巴瘤有较高治愈率

2014-07-21

chengjn (审核中...)

前往app查看评论内容

#西妥昔#

Lancet Oncol：不推荐根治性放化疗合并西妥昔单抗治疗食管癌

2013-06-26

chengjn (审核中...)

前往app查看评论内容

#西妥昔#

Lancet Oncol：在卡培他滨-顺铂基础上联用西妥昔单抗不能改善晚期胃癌患者临床预后

2013-12-22

chengjn (审核中...)

前往app查看评论内容

#西妥昔#

JCO：肿瘤早期萎缩情况可预测含西妥昔单抗一线治疗的转移性结直肠癌患者长期结局

2013-11-14

chengjn (审核中...)

前往app查看评论内容

#西妥昔#

JCO：西妥昔单抗联合顺铂可改善三阴性乳腺癌患者生存

2013-12-13

chengjn (审核中...)

前往app查看评论内容

#西妥昔#

ASCO 2013：头对头研究显示晚期结肠癌一线治疗西妥昔单抗优于贝伐单抗

2014-01-12

chengjn (审核中...)

前往app查看评论内容

#西妥昔#

JAMA：FOLFOX方案添加西妥昔单抗治疗结肠癌并未获益

2013-01-25

chengjn (审核中...)

前往app查看评论内容

#西妥昔#

JAMA：结肠癌术后西妥昔单抗不改善患者无病存活率

2012-11-19

chengjn (审核中...)

前往app查看评论内容

#西妥昔#

JAMA：结肠癌术后添加西妥昔单抗的疗效

2012-04-29

chengjn (审核中...)

前往app查看评论内容

#西妥昔#

JCO：西妥昔单抗升级剂量治疗转移性结直肠癌

2012-09-11

chengjn (审核中...)

前往app查看评论内容

#西妥昔#

Annal Onco：西妥昔单抗/吉西他滨/调强放疗（IMRT）新辅助化放疗治胰腺导管腺癌有效

2012-11-23

科室
- - 订阅+
  - 更多科室
工具
服务